Eris Lifesciences Limited has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. This certificate was received from M/s. MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent (RTA). The RTA confirmed that the securities received from depository participants for dematerialisation during the quarter were processed and listed on the stock exchanges. They also confirmed that the security certificates received were either accepted or rejected, and those accepted were mutilated and cancelled after verification, with the depositories' names substituted in the register of members within the prescribed timelines. The company has duly confirmed and certified this information and is providing it for the information and records of the stock exchanges and depositories.
